Chinese Medicine Prolongs Overall Survival of Chinese Patients with Advanced Gastric Cancer: Treatment Pattern and Survival Analysis of a 20-Year Real-World Study-Reference-Cited by-同舟云学术

Chinese Medicine Prolongs Overall Survival of Chinese Patients with Advanced Gastric Cancer: Treatment Pattern and Survival Analysis of a 20-Year Real-World Study

Published:2024-05-27 Issue:6 Volume:30 Page:489-498
ISSN:1672-0415
Container-title:Chinese Journal of Integrative Medicine
language:en
Short-container-title:Chin. J. Integr. Med.

Author:

Cao Ni-da,Zhu Xiao-hong,Ma Fang-qi,Xu Yan,Dong Jia-huan,Qin Meng-meng,Liu Tian-shu,Zhu Chun-chao,Guo Wei-jian,Ding Hong-hua,Guo Yuan-biao,Liu Li-kun,Song Jin-jie,Wu Ji-ping,Cheng Yue-lei,Zeng Lin,Zhao Ai-guang

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11655-024-4107-8.pdf

Reference40 articles.

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209–249.

2. Xia CF, Dong XS, Li H, Cao MM, Sun DQ, He SY, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J 2022;135:584–590.

3. Qi CS, Cheng SY, Shen L. Current status and research progress of third-line treatment for gastric cancer patients in China. Chin J Oncol (Chin) 2020;42:983–988.

4. Cutsem EV, Moiseyenko VM, Tjulandin S, Majlis A, Constenla M, Boni C, et al. V325 Study Group. Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group. J Clin Oncol 2006;24:4991–4997.

5. Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, Takagi M, et al. S-1 plus cisplatin versus S-1 alone for first line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol 2008;9:215–221.